60 Degrees Valuation
| SXTP Stock | 3.51 0.44 11.14% |
At this time, the entity appears to be undervalued. 60 Degrees Pharmaceu owns a latest Real Value of USD6.88 per share. The recent price of the entity is USD3.51. Our model approximates the value of 60 Degrees Pharmaceu from evaluating the entity fundamentals such as Return On Asset of -0.7, shares owned by insiders of 2.05 %, and Price To Sales of 3.31 X as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting 60 Degrees' valuation include:
Enterprise Value | Enterprise Value Ebitda 22.2342 | Price Sales 3.3101 | Enterprise Value Revenue 10.7272 |
Undervalued
Today
Please note that 60 Degrees' price fluctuation is dangerous at this time. Calculation of the real value of 60 Degrees Pharmaceu is based on 3 months time horizon. Increasing 60 Degrees' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
60 Degrees' intrinsic value may or may not be the same as its current market price of 3.51, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.51 | Real 6.88 | Target 17.6 | Hype 3.22 |
The intrinsic value of 60 Degrees' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence 60 Degrees' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of 60 Degrees Pharmaceuticals helps investors to forecast how SXTP stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of 60 Degrees more accurately as focusing exclusively on 60 Degrees' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use 60 Degrees' intrinsic value based on its ongoing forecasts of 60 Degrees' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against 60 Degrees' closest peers.
60 Degrees Cash |
|
SXTP Revenue by Product
60 Degrees Total Value Analysis
60 Degrees Pharmaceuticals is at this time anticipated to have valuation of 10.12 M with market capitalization of 4.52 M, debt of 155.89 K, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the 60 Degrees fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
10.12 M | 4.52 M | 155.89 K |
60 Degrees Investor Information
The company recorded a loss per share of 3.1. 60 Degrees Pharmaceu had not issued any dividends in recent years. The entity had 1:4 split on the 20th of January 2026. Based on the key indicators related to 60 Degrees' liquidity, profitability, solvency, and operating efficiency, 60 Degrees Pharmaceuticals is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.60 Degrees Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. 60 Degrees has an asset utilization ratio of 10.55 percent. This connotes that the Company is making USD0.11 for each dollar of assets. An increasing asset utilization means that 60 Degrees Pharmaceuticals is more efficient with each dollar of assets it utilizes for everyday operations.60 Degrees Profitability Analysis
Based on 60 Degrees' profitability indicators, 60 Degrees Pharmaceuticals may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in March. Profitability indicators assess 60 Degrees' ability to earn profits and add value for shareholders.Net Loss | First Reported 2010-12-31 | Previous Quarter -7.2 M | Current Value -7.5 M | Quarterly Volatility 1.8 M |
For 60 Degrees profitability analysis, we use financial ratios and fundamental drivers that measure the ability of 60 Degrees Pharmaceu to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well 60 Degrees utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between 60 Degrees's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of 60 Degrees over time as well as its relative position and ranking within its peers.
60 Degrees Earnings per Share Projection vs Actual
By analyzing 60 Degrees' earnings estimates, investors can diagnose different trends across 60 Degrees' analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for 60 Degrees Pharmaceuticals is based on EPS before non-recurring items and includes expenses related to employee stock options.60 Degrees Ownership Allocation
Roughly 92.43 % of 60 Degrees outstanding shares are held by general public with 2.05 percent owned by insiders and only 5.52 (percent) by institutions.60 Degrees Profitability Analysis
The company reported the previous year's revenue of 607.57 K. Net Loss for the year was (7.96 M) with profit before overhead, payroll, taxes, and interest of 585.86 K.About 60 Degrees Valuation
The stock valuation mechanism determines 60 Degrees' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of 60 Degrees Pharmaceu based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of 60 Degrees. We calculate exposure to 60 Degrees's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of 60 Degrees's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 200.5 K | 252.9 K | |
| Pretax Profit Margin | (15.06) | (15.81) | |
| Operating Profit Margin | (18.39) | (19.31) | |
| Net Loss | (15.04) | (15.79) | |
| Gross Profit Margin | 0.42 | 0.44 |
60 Degrees Current Valuation Indicators
60 Degrees' valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final 60 Degrees' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as 60 Degrees, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use 60 Degrees' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes 60 Degrees' worth.Additional Tools for SXTP Stock Analysis
When running 60 Degrees' price analysis, check to measure 60 Degrees' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 60 Degrees is operating at the current time. Most of 60 Degrees' value examination focuses on studying past and present price action to predict the probability of 60 Degrees' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 60 Degrees' price. Additionally, you may evaluate how the addition of 60 Degrees to your portfolios can decrease your overall portfolio volatility.